YAP1 and lung carcinoma: Activation of YAP-mediated transcriptional hubs in the nuclei is associated with resistance of anti-PD-1 in a mouse model of lung cancer cells, and inhibition of YAP can enhance the efficacy of anti-PD-1 therapy 116.